Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$321.55 - $374.67 $197,753 - $230,422
615 New
615 $224,000
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $175,078 - $217,578
-746 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $167,738 - $208,163
746 New
746 $206,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cohen Lawrence B Portfolio

Follow Cohen Lawrence B and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Lawrence B with notifications on news.